Samarth Kulkarni, Chief Executive Officer

CRSP 166,542 shares

The estimated Net Worth of Samarth Kulkarni is at least $6,656,683.74. Samarth Kulkarni owns over 166,542 units of CRISPR Therapeutics AG stock worth over $6,656,683.74.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
1st March 2019CRSP - CRISPR Therapeutics AG748Payment by withholding166,542$39.97$29,897.56$6,656,683.74
29th April 2019CRSP - CRISPR Therapeutics AG20,000Open or private sale166,542$42.03$840,600.00$6,999,760.26
29th April 2019CRSP - CRISPR Therapeutics AG20,000Exercise of derivative186,542$1.81$36,200.00$337,641.02
1st June 2019CRSP - CRISPR Therapeutics AG741Payment by withholding165,801$35.57$26,357.37$5,897,541.57
17th June 2019CRSP - CRISPR Therapeutics AG20,000Open or private sale165,801$46.00$920,000.00$7,626,846.00
17th June 2019CRSP - CRISPR Therapeutics AG20,000Exercise of derivative185,801$1.81$36,200.00$336,299.81
1st September 2019CRSP - CRISPR Therapeutics AG740Payment by withholding165,061$46.21$34,195.40$7,627,468.81
1st December 2019CRSP - CRISPR Therapeutics AG741Payment by withholding164,320$71.65$53,092.65$11,773,528.00
16th December 2019CRSP - CRISPR Therapeutics AG8,000Exercise of derivative172,320$1.81$14,480.00$311,899.20
2nd March 2020CRSP - CRISPR Therapeutics AG794Payment by withholding171,526$52.74$41,875.56$9,046,281.24
20th May 2020CRSP - CRISPR Therapeutics AG10,693Open or private sale171,526$65.28$698,039.04$11,197,217.28
20th May 2020CRSP - CRISPR Therapeutics AG10,693Exercise of derivative182,219$1.81$19,354.33$329,816.39
19th May 2020CRSP - CRISPR Therapeutics AG4,307Open or private sale171,526$65.16$280,644.12$11,176,634.16
19th May 2020CRSP - CRISPR Therapeutics AG4,307Exercise of derivative175,833$1.81$7,795.67$318,257.73
2nd June 2020CRSP - CRISPR Therapeutics AG779Payment by withholding170,747$66.26$51,616.54$11,313,696.22
1st June 2020CRSP - CRISPR Therapeutics AG5,575Open or private sale171,526$65.26$363,824.50$11,193,786.76
1st June 2020CRSP - CRISPR Therapeutics AG9,300Open or private sale177,101$64.61$600,873.00$11,442,495.61
1st June 2020CRSP - CRISPR Therapeutics AG2,400Open or private sale186,401$63.57$152,568.00$11,849,511.57
1st June 2020CRSP - CRISPR Therapeutics AG17,275Exercise of derivative188,801$1.81$31,267.75$341,729.81
2nd September 2020CRSP - CRISPR Therapeutics AG779Payment by withholding169,968$94.15$73,342.85$16,002,487.20